… researchers are now exploring cannabidiol (CBD), a component of marijuana, … of cannabis called cannabidiol (CBD) could possibly help. But … with naloxone, they found CBD accelerated the medication’s … tissue samples showed the CBD component reversed fentanyl’s …
This article was featured in One Story to Read Today, a newsletter in which our editors recommend a single must-read from The Atlantic, Monday through Friday. Sign up for it here.
Three years ago, while the nation’s attention was on the 2020 presidential election, voters in Oregon took a dramatic step back from America’s long-running War on Drugs. By a 17-point margin, Oregonians approved Ballot Measure 110, which eliminated criminal penalties for possessing small amounts of any drug, including cocaine, heroin, and methamphetamine. When the policy went into effect early the next year, it lifted the fear of prosecution for the state’s drug users and launched Oregon on an experiment to determine whether a long-sought goal of the drug-policy reform movement—decriminalization—could help solve America’s drug problems.
Early results of this reform effort, the first of its kind in any state, are now coming into view, and so far, they are not encouraging. State leaders have acknowledged faults with the policy’s implementation and enforcement measures. And Oregon’s drug problems have not improved. Last year, the state experienced one of the sharpest rises in overdose deaths in the nation and had one of the highest percentages of adults with a substance-use disorder. During one two-week period last month, three children under the age of 4 overdosed in Portland after ingesting fentanyl.
For decades, drug policy in America centered on using law enforcement to target people who sold, possessed, or used drugs—an approach long supported by both Democratic and Republican politicians. Only in recent years, amid an epidemic of opioid overdoses and a national reconsideration of racial inequities in the criminal-justice system, has the drug-policy status quo begun to break down, as a coalition of health workers, criminal-justice-reform advocates, and drug-user activists have lobbied for a more compassionate and nuanced response. The new approach emphasizes reducing overdoses, stopping the spread of infectious disease, and providing drug users with the resources they need—counseling, housing, transportation—to stabilize their lives and gain control over their drug use.
Oregon’s Measure 110 was viewed as an opportunity to prove that activists’ most groundbreaking idea—sharply reducing the role of law enforcement in the government’s response to drugs—could work. The measure also earmarked hundreds of millions of dollars in cannabis tax revenue for building a statewide treatment network that advocates promised would do what police and prosecutors couldn’t: help drug users stop or reduce their drug use and become healthy, engaged members of their communities. The day after the measure passed, Kassandra Frederique, executive director of the Drug Policy Alliance, one of the nation’s most prominent drug-policy reform organizations, issued a statement calling the vote a “historic, paradigm-shifting win” and predicting that Oregon would become “a model and starting point for states across the country to decriminalize drug use.”
But three years later, with rising overdoses and delays in treatment funding, even some of the measure’s supporters now believe that the policy needs to be changed. In a nonpartisan statewide poll earlier this year, more than 60 percent of respondents blamed Measure 110 for making drug addiction, homelessness, and crime worse. A majority, including a majority of Democrats, said they supported bringing back criminal penalties for drug possession. This year’s legislative session, which ended in late June, saw at least a dozen Measure 110–related proposals from Democrats and Republicans alike, ranging from technical fixes to full restoration of criminal penalties for drug possession. Two significant changes—tighter restrictions on fentanyl and more state oversight of how Measure 110 funding is distributed—passed with bipartisan support.
Few people consider Measure 110 “a success out of the gate,” Tony Morse, the policy and advocacy director for Oregon Recovers, told me. The organization, which promotes policy solutions to the state’s addiction crisis, initially opposed Measure 110; now it supports funding the policy, though it also wants more state money for in-patient treatment and detox services. As Morse put it, “If you take away the criminal-justice system as a pathway that gets people into treatment, you need to think about what is going to replace it.”
Many advocates say the new policy simply needs more time to prove itself, even if they also acknowledge that parts of the ballot measure had flaws; advocates worked closely with lawmakers on the oversight bill that passed last month. “We’re building the plane as we fly it,” Haven Wheelock, a program supervisor at a homeless-services provider in Portland who helped put Measure 110 on the ballot, told me. “We tried the War on Drugs for 50 years, and it didn’t work … It hurts my heart every time someone says we need to repeal this before we even give it a chance.”
Workers from the organization Central City Concern hand out Narcan in Portland, Oregon, on April 5. (Jordan Gale)
Measure 110 went into effect at a time of dramatic change in U.S. drug policy. Departing from precedent, the Biden administration has endorsed and increased federal funding for a public-health strategy called harm reduction; rather than pushing for abstinence, harm reduction emphasizes keeping drug users safe—for instance, through the distribution of clean syringes and overdose-reversal medications. The term harm reduction appeared five times in the ballot text of Measure 110, which forbids funding recipients from “mandating abstinence.”
Matt Sutton, the director of external relations for the Drug Policy Alliance, which helped write Measure 110 and spent more than $5 million to pass it, told me that reform advocates viewed the measure as the start of a nationwide decriminalization push. The effort started in Oregon because the state had been an early adopter of marijuana legalization and is considered a drug-policy-reform leader. Success would mean showing the rest of the country that “people did think we should invest in a public-health approach instead of criminalization,” Sutton said.
To achieve this goal, Measure 110 enacted two major changes to Oregon’s drug laws. First, minor drug possession was downgraded from a misdemeanor to a violation, similar to a traffic ticket. Under the new law, users caught with up to 1 gram of heroin or methamphetamine, or up to 40 oxycodone pills, are charged a $100 fine, which can be waived if they call a treatment-referral hotline. (Selling, trafficking, and possessing large amounts of drugs remain criminal offenses in Oregon.) Second, the law set aside a portion of state cannabis tax revenue every two years to fund a statewide network of harm-reduction and other services. A grant-making panel was created to oversee the funding process. At least six members of the panel were required to be directly involved in providing services to drug users; at least two had to be active or former drug users themselves; and three were to be “members of communities that have been disproportionately impacted” by drug criminalization, according to the ballot measure.
Backers of Measure 110 said the law was modeled on drug policies in Portugal, where personal drug possession was decriminalized two decades ago. But Oregon’s enforcement-and-treatment-referral system differs from Portugal’s. Users caught with drugs in Portugal are referred to a civil commission that evaluates their drug use and recommends treatment if needed, with civil sanctions for noncompliance. Portugal’s state-run health system also funds a nationwide network of treatment services, many of which focus on sobriety. Sutton said drafters of Measure 110 wanted to avoid anything that might resemble a criminal tribunal or coercing drug users into treatment. “People respond best when they’re ready to access those services in a voluntary way,” he said.
Almost immediately after taking effect, Measure 110 encountered problems. A state audit published this year found that the new law was “vague” about how state officials should oversee the awarding of money to new treatment programs, and set “unrealistic timelines” for evaluating and funding treatment proposals. As a result, the funding process was left largely to the grant-making panel, most of whose members “lacked experience in designing, evaluating and administrating a governmental-grant-application process,” according to the audit. Last year, supporters of Measure 110 accused state health officials, preoccupied with the coronavirus pandemic, of giving the panel insufficient direction and resources to handle a flood of grant applications. The state health authority acknowledged missteps in the grant-making process.
The audit described a chaotic process, with more than a dozen canceled meetings, potential conflicts of interest in the selection of funding recipients, and lines of applicant evaluations left blank. Full distribution of the first biennial payout of cannabis tax revenue—$302 million for harm reduction, housing, and other services—did not occur until late 2022, almost two years after Measure 110 passed. Figures released by the state last month show that, in the second half of 2022, recipients of Measure 110 funding provided some form of service to roughly 50,000 “clients,” though the Oregon Health Authority has said that a single individual could be counted multiple times in that total. (A study released last year by public-health researchers in Oregon found that, as of 2020, more than 650,000 Oregonians required, but were not receiving, treatment for a substance-use disorder.)
Meanwhile, the new law’s enforcement provisions have proved ineffectual. Of 5,299 drug-possession cases filed in Oregon circuit courts since Measure 110 went into effect, 3,381 resulted in a recipient failing to pay the fine or appear in court and facing no further penalties, according to the Oregon Judicial Department; about 1,300 tickets were dismissed or are pending. The state audit found that, during its first 15 months in operation, the treatment-referral hotline received just 119 calls, at a cost to the state of $7,000 per call. A survey of law-enforcement officers conducted by researchers at Portland State University found that, as of July 2022, officers were issuing an average of just 300 drug-possession tickets a month statewide, compared with 600 drug-possession arrests a month before Measure 110 took effect and close to 1,200 monthly arrests prior to the outbreak of COVID-19.
“Focusing on these tickets even though they’ll be ineffective—it’s not a great use of your resources,” Sheriff Nate Sickler of Jackson County, in the rural southern part of the state, told me of his department’s approach.
Advocates have celebrated a plunge in arrests. “For reducing arrests of people of color, it’s been an overwhelming success,” says Mike Marshall, the director of Oregon Recovers. But critics say that sidelining law enforcement has made it harder to persuade some drug users to stop using. Sickler cited the example of drug-court programs, which multiple studies have shown to be highly effective, including in Jackson County. Use of such programs in the county has declined in the absence of criminal prosecution, Sickler said: “Without accountability or the ability to drive a better choice, these individuals are left to their own demise.”
The consequences of Measure 110’s shortcomings have fallen most heavily on Oregon’s drug users. In the two years after the law took effect, the number of annual overdoses in the state rose by 61 percent, compared with a 13 percent increase nationwide, according to the Centers for Disease Control and Prevention. In neighboring Idaho and California, where drug possession remains subject to prosecution, the rate of increase was significantly lower than Oregon’s. (The spike in Washington State was similar to Oregon’s, but that comparison is more complicated because Washington’s drug policy has fluctuated since 2021.) Other states once notorious for drug deaths, including West Virginia, Indiana, and Arkansas, are now experiencing declines in overdose rates.
In downtown Portland this spring, police cleared out what The Oregonian called an “open-air drug market” in a former retail center. Prominent businesses in the area, including the outdoor-gear retailer REI, have closed in recent months, in part citing a rise in shoplifting and violence. Earlier this year, Portland business owners appeared before the Multnomah County Commission to ask for help with crime, drug-dealing, and other problems stemming from a behavioral-health resource center operated by a harm-reduction nonprofit that was awarded more than $4 million in Measure 110 funding. In April, the center abruptly closed following employee complaints that clients were covering walls with graffiti and overdosing on-site. A subsequent investigation by the nonprofit found that a security contractor had been using cocaine on the job. The center reopened two weeks later with beefed-up security measures.
Portland’s Democratic mayor, Ted Wheeler, went so far as to attempt an end run around Measure 110 in his city. Last month, Wheeler unveiled a proposal to criminalize public drug consumption in Portland, similar to existing bans on open-air drinking, saying in a statement that Measure 110 “is not working as it was intended to.” He added, “Portland’s substance-abuse problems have exploded to deadly and disastrous proportions.” Wheeler withdrew the proposal days later after learning that an older state law prohibits local jurisdictions from banning public drug use.
Despite shifting public opinion on Measure 110, many Oregon leaders are not ready to give up on the policy. Earlier this month, Oregon Governor Tina Kotek signed legislation that strengthens state oversight of Measure 110 and requires an audit, due no later than December 2025, of about two dozen aspects of the measure’s performance, including whether it is reducing overdoses. Other bills passed by the legislature’s Democratic majority strengthened criminal penalties for possession of large quantities of fentanyl and mandated that school drug-prevention programs instruct students about the risks of synthetic opioids. Republican proposals to repeal Measure 110 outright or claw back tens of millions of dollars in harm-reduction funding were not enacted.
The fallout from Measure 110 has received some critical coverage from media outlets on the right. “It is predictable,” a scholar from the Hudson Institute told Fox News. “It is a tragedy and a self-inflicted wound.” (Meanwhile, in Portugal, the model for Oregon, some residents are raising questions about their own nation’s decriminalization policy.) But so far Oregon’s experience doesn’t appear to have stopped efforts to bring decriminalization to other parts of the United States. “We’ll see more ballot initiatives,” Sutton, of the Drug Policy Alliance, said, adding that advocates are currently working with city leaders to decriminalize drugs in Washington, D.C.
Supporters of Measure 110 are now seeking to draw attention to what they say are the policy’s overlooked positive effects. This summer, the Health Justice Recovery Alliance, a Measure 110 advocacy organization, is leading an effort to spotlight expanded treatment services and boost community awareness of the treatment-referral hotline. Advocates are also coordinating with law-enforcement agencies to ensure that officers know about local resources for drug users. “People are hiring for their programs; outreach programs are expanding, offering more services,” Devon Downeysmith, the communications director for the group, told me.
An array of services around the state have been expanded through the policy: housing for pregnant women awaiting drug treatment; culturally specific programs for Black, Latino, and Indigenous drug users; and even distribution of bicycle helmets to people unable to drive to treatment meetings. “People often forget how much time it takes to spend a bunch of money and build services,” said Wheelock, the homeless-services worker, whose organization received more than $2 million in funding from Measure 110.
Still, even some recipients of Measure 110 funding wonder whether one of the law’s pillars—the citation system that was supposed to help route drug users into treatment—needs to be rethought. “Perhaps some consequences might be a helpful thing,” says Julia Pinsky, a co-founder of Max’s Mission, a harm-reduction nonprofit in southern Oregon. Max’s Mission has received $1.5 million from Measure 110, enabling the organization to hire new staff, open new offices, and serve more people. Pinsky told me she is proud of her organization’s work and remains committed to the idea that “you shouldn’t have to go to prison to be treated for substance use.” She said that she doesn’t want drug use to “become a felony,” but that some people aren’t capable of stopping drug use on their own. “They need additional help.”
Brandi Fogle, a regional manager for Max’s Mission, says her own story illustrates the complex trade-offs involved in reforming drug policy. Three and a half years ago, she was a homeless drug user, addicted to heroin and drifting around Jackson and Josephine Counties. Although she tried to stop numerous times, including one six-month period during which she was prescribed the drug-replacement medication methadone, she told me that a 2020 arrest for drug possession was what finally turned her life around. She asked to be enrolled in a 19-month drug-court program that included residential treatment, mandatory 12-step meetings, and a community-service project, and ultimately was hired by Pinsky.
Since Measure 110 went into effect, Fogle said, she has gotten pushback from members of the community for the work Max’s Mission does. She said that both the old system of criminal justice and the new system of harm reduction can benefit drug users, but that her hope now is to make the latter approach more successful. “Everyone is different,” Fogle said. “Drug court worked for me because I chose it, and I wouldn’t have needed drug court in the first place if I had received the kind of services Max’s Mission provides. I want to offer people that chance.”
THURSDAY, March 30, 2023 (HealthDay News) — Drug overdose deaths — both accidental and intentional — have quadrupled over the past 20 years among older adults in the United States, a new study finds.
This increase in people ages 65 and older suggests the need for greater mental health and substance use policies, the authors said.
“The dramatic rise in overdose fatalities among adults over 65 years of age in the past two decades underscores how important it is for clinicians and policymakers to think of overdose as a problem across the life span,” said co-author Chelsea Shover, an assistant professor of medicine at the University of California, Los Angeles David Geffen School of Medicine.
“Updating Medicare to cover evidence-based treatment for substance use disorders is crucial, as is providing harm reduction supplies such as naloxone to older adults,” Shover said in a school news release.
About three-fourths of those who died accidentally were using illicit drugs, including synthetic opioids such as fentanyl, heroin, cocaine and methamphetamine. In 67% of intentional overdoses, seniors used prescription medication, including opioids, antidepressants, benzodiazepines, antiepileptics and sedatives.
The researchers calculated overdose deaths among seniors from 2002 to 2021, using a database from the U.S. Centers for Disease Control and Prevention. The investigators compared demographics, specific drugs, and whether the deaths were intentional, unintentional or undetermined.
They found that fatal overdoses quadrupled from 1,060 in 2002, which was 3 per 100,000, to 6,702 in 2021, or 12 per 100,000. Black seniors had the highest rates, at 30.9 per 100,000.
By 2021, 1 in 370 senior deaths was from an overdose, the report noted. About 57% of those involved opioids, 39% involved stimulants and 18% included a combination of the two types of drugs.
About 13% of overdoses in 2021 were intentional and 83% were unintentional. Another 4% were undetermined, and 0.7% — five people — were murdered.
Women comprised 57% of the intentional overdoses and 29% of the accidental overdoses, according to the study.
The researchers also determined that 37%, of overdoses among Asian-Americans were intentional compared to 17% among white people and 1% among Black people.
Deaths from alcohol poisoning rose from less than 0.03 per 100,000 to 0.5 per 100,000 during the study period.
“Even though drug overdose remains an uncommon cause of death among older adults in the U.S., the quadrupling of fatal overdoses among older adults should be considered in evolving policies focused on the overdose epidemic,” the researchers wrote. “Current proposals to improved mental health and substance use disorder coverage within Medicare, for example, applying mental health parity rules within Medicare, acquire greater urgency in light of this study’s results.”
Study findings were published March 29 in JAMA Psychiatry.
More information
The U.S. National Safety Council has more on drug overdoses.
TUESDAY, Dec. 20, 2022 (HealthDay News) — Deaths of teens from drug overdoses soared starting in late 2019, and though they appear to be on the decline, they remain much higher than in 2019, U.S. health officials report.
Most of these deaths are due to illegally made fentanyl mixed with other drugs, said study author Lauren Tanz, an epidemiologist at the U.S. Centers for Disease Control and Prevention.
“Adolescent overdose deaths increased substantially between 2019 and 2021; however, these deaths are preventable, and overdoses do not have to end in death,” Tanz said. “We all play a role as parents, family members, friends and communities to prevent overdoses and save lives.”
Using data from the CDC’s State Unintentional Drug Overdose Reporting System, the researchers found that overdose deaths among 10- to 19-year-olds began to rise in late 2019. Among 14- to 18-year-olds, overdose deaths jumped 94% from 2019 to 2020 as the COVID-19 pandemic raged on.
Between the second half of 2019 and the second half of 2021, monthly overdose deaths among teens jumped a median 109%, Tanz said. Those involving illicitly manufactured fentanyl rose 182%. (Median means half of months had higher rates, half lower.)
About 9 in 10 overdose deaths involved at least one opioid, more than 8 in 10 involved illicitly manufactured fentanyl, and nearly one-quarter involved counterfeit pills, according to the report.
The availability of fentanyl has driven the surge in overdose deaths, according to Dr. Nora Volkow, director of the U.S. National Institute on Drug Abuse.
“Over the past few years, there has been a marked expansion in the drug supply of illicit fentanyl, a cheap, very potent synthetic opioid drug,” she said. “While people may seek out fentanyl intentionally in some cases, many people are not aware whether the drug they are using contains fentanyl, which can put them at high risk of overdosing.”
The surge of fentanyl in the drug supply is of enormous concern, Volkow said, especially the contamination of counterfeit pills made to resemble prescription drugs such as ADHD (attention-deficit/hyperactivity disorder) medications, sleep aids or painkillers.
“It is absolutely crucial to educate young people that pills purchased via social media, given to someone by a friend or obtained from an unknown source may contain deadly fentanyl,” Volkow said.
Mental illness also contributed to the surge, Tanz said.
More than 40% of teens who died from a drug overdose had a history of a mental illness, such as depression or suicidal or self-harm behavior, or had been treated for a mental health condition, the researchers found.
“Our results show that overdose deaths among adolescents continued to rise from January to June 2020, coinciding with the pandemic’s onset, and was possibly related to declining mental health,” Tanz said. Social isolation and lack of access to school-based mental health services may also have played a role.
Linda Richter, vice president for prevention research and analysis at the Partnership to End Addiction, in New York City, said, “This report should be a wake-up call to all families, communities, educators, health professionals, policymakers and young people themselves that what was an opioid epidemic is now a fentanyl crisis causing an unacceptable number of completely preventable deaths among teenagers.” She was not involved in the study but reviewed the findings.
“These deaths are rising as illegal drug use is generally declining among youth, which indicates that it’s not that more teens are using dangerous drugs, but rather that those who are using the drugs are increasingly likely to die from them,” Richter said.
Volkow struck a similar chord.
“Drug use among adolescents is becoming more dangerous, but not necessarily more common,” she said.
Researcher Tanz said steps to prevent overdose deaths are urgently needed. These include:
Promoting prevention.
Monitoring risk behaviors, such as poor school performance and teens associating with others who use drugs; promoting positive social and life skills; and improving well-being.
Educating teens about the dangers of illicitly manufactured fentanyl and counterfeit pills.
Educating family and friends on ways to recognize warning signs of drug use.
Learning how to respond to an overdose.
Training friends and family to use naloxone, a medicine used to rapidly reverse an opioid overdose, and expanding access to it.
Ensuring access to effective treatment for mental health problems and substance abuse.
The study was published Dec. 16 in the CDC’s Morbidity and Mortality Weekly Report.
More information
The U.S. Department of Health and Human Services has more about preventing drug overdoses.
SOURCES: Lauren Tanz, ScD, MSPH, epidemiologist, U.S. Centers for Disease Control and Prevention, Atlanta; Nora Volkow, MD, director, U.S. National Institute on Drug Abuse; Linda Richter, PhD, vice president, prevention research and analysis, Partnership to End Addiction, New York City; Morbidity and Mortality Weekly Report, Dec. 16, 2022
With more Americans now dying of drug overdose than traffic accidents, the Church of Scientology Seattle and the Foundation for a Drug-Free World join forces to combat the deadly opioid epidemic.
Press Release –
updated: Jul 26, 2017
SEATTLE, Wash., July 26, 2017 (Newswire.com)
– The Church of Scientology Seattle is sponsoring local events this summer to highlight the dangers of opioid abuse and solutions to this deadly epidemic.
At an open forum at the Church, organized by the Foundation for a Drug-Free World, Terrie Johnston, Crime Prevention Coordinator with the Seattle Police Department, briefed community leaders on the link between drug use and crime.
I could hold this Church up as a model for what we want every neighborhood to do.
Terrie Johnston, Crime Prevention Coordinator with the Seattle Police Department
As in many parts of the country, Ms. Johnston said, opioid use has been escalating in Seattle. The Washington State Department of Health reports 995 opioid-related overdose deaths from 2012 to 2016 in Seattle and the rest of King County. In that same time period, more than 1,700 died in counties across the state. And nationwide, overdoses have surpassed traffic accidents as the No. 1 cause of accidental deaths.
Ms. Johnston indicated that the cost to the community is no less dramatic: As much as 75 percent of crimes committed in Seattle involve drugs—directly or indirectly. She also noted an increase in accident rates with a higher proportion of DUIs attributed to marijuana use.
Ms. Johnston acknowledged the Drug-Free World volunteers for reaching out in the community with the truth about drugs. “You never know the ripple effects of what you do,” she said. “It’s been a great partnership. I could hold this Church up as a model for what we want every neighborhood to do.”
The Church of Scientology and its members support the Foundation for a Drug-Free World, whose Truth About Drugs campaign is one of the world’s largest nongovernmental drug education and prevention initiatives. Thanks to this support, the Foundation provides—free of charge—drug education booklets, videos and educator guides to teachers, mentors and civic and community leaders.